510(k) vs PMA: Choosing the US Regulatory Pathway

Every medical device entering the United States market travels one of two main regulatory roads: the 510(k) premarket notification, or the premarket approval known as PMA. The choice is not a preference; it follows from the device’s risk class and whether a predicate device exists. Choosing wrong means a rejected submission, a wasted year and a stalled launch. This guide explains how the two pathways differ and how to determine which one a product belongs on.

Device Class Determines the Pathway

The FDA groups devices into three classes by risk. Class I devices, low risk such as examination tables and manual instruments, mostly need only general controls and registration, with a minority requiring 510(k). Class II devices, moderate risk including many powered hospital devices, typically require 510(k) clearance demonstrating substantial equivalence to a legally marketed predicate. Class III devices, the highest risk such as implantables and life-sustaining equipment, require PMA unless they qualify for a pre-amendments exemption.

The class of a device follows its product code and regulation number, which the buyer or manufacturer looks up in the FDA classification database. The classification, not the marketing preference, decides the pathway, and the first step of any US market entry plan is confirming the correct product code and its associated class.

How the 510(k) Pathway Works

The 510(k) asks one question: is the new device substantially equivalent to a predicate device already legally marketed? Substantial equivalence compares intended use and technological characteristics. When the new device shares the intended use and does not raise different questions of safety and effectiveness, the pathway applies. Most 510(k) submissions complete review in 90 to 150 FDA days, though the full timeline from submission to clearance typically spans 6 to 12 months including questions and responses.

The submission package contains device description, intended use statement, comparison to the predicate, performance testing and, where the technology differs, bench or animal data. Clinical data appears in a minority of 510(k)s, roughly 10 to 15 percent, which is the pathway’s main cost advantage: a typical 510(k) program with testing runs USD 30,000 to USD 150,000, far below the PMA cost floor.

How the PMA Pathway Works

PMA applies to Class III devices and asks a different question: does the device demonstrate safety and effectiveness on its own evidence? There is no predicate comparison. The submission contains the full design history, manufacturing information, and in most cases clinical trial data demonstrating the device’s performance in its intended population. FDA review runs 180 FDA days after filing, with the total program from trial design to approval typically spanning 2 to 5 years and costing USD 500,000 to several million depending on the trial.

The gap between the pathways is why classification matters so much to commercial planning. A device that lands in Class III faces years of clinical work; the same product positioned against a Class II predicate with a defensible equivalence argument clears in months. Manufacturers who get this wrong see the difference in their launch budget.

Alignment with International Quality Systems

Both pathways presume a quality system that meets the FDA’s quality system regulation, which aligns closely with ISO 13485. The electrical safety and performance evidence that supports a submission draws on the IEC 60601 series, such as the operating table standard IEC 60601-2-46, and the test reports from accredited laboratories carry directly into the 510(k) or PMA package. Building the technical file once, with IEC testing done to the current edition, serves the US submission and the international registrations together.

Procurement teams buying finished devices should confirm which pathway the product cleared and keep the clearance documentation on file, because hospital value analysis committees ask for it. Device selection guidance from WHO reinforces verifying regulatory status as part of procurement, and independent evaluations from ECRI reference the clearance pathway when assessing equipment.

Decision Checklist for Manufacturers and Buyers

The decision sequence runs: confirm the product code and device class; if Class II, identify the predicate and build the substantial equivalence argument; if Class III, check the pre-amendments status and whether a de novo or PMA supplement route fits; then budget the testing and review timeline against the launch date. For buyers, the checklist is shorter: ask for the 510(k) number or PMA number, confirm it matches the device model, and verify the labelling matches the cleared indications. A device marketed outside its cleared indications creates liability for both sides.

For hospital equipment cleared for the US market, see our من المنتجات and the compliance documentation available through our OR solutions pages.

الأسئلة المتكررة

What is the difference between 510(k) and PMA?
The 510(k) proves substantial equivalence to an existing predicate device and suits Class II devices. PMA proves safety and effectiveness with the device’s own evidence, usually clinical trials, and applies to Class III devices.

How long does a 510(k) take?
FDA review runs 90 to 150 days after submission, with the full timeline from submission to clearance typically 6 to 12 months including questions and responses.

How much does a PMA cost?
A PMA program typically costs USD 500,000 to several million and spans 2 to 5 years from trial design to approval, while a 510(k) program with testing runs USD 30,000 to 150,000.

Do all Class III devices need a PMA?
Class III devices require PMA unless they qualify for pre-amendments status or fit an alternative route. The device’s product code and regulation number determine the class and pathway.

قبل الطلب، قم بإجراء فحوصات الشهادات الخمسة في قائمة إعادة التحقق لـ CE MDR مقابل MDD.

للحصول على الأنواع الكاملة لأبواب غرف العمليات، وسلوك الضغط، وفحوصات التسليم، راجع دليل أبواب غرف العمليات المنزلقة والتحكم في الحركة.